192 related articles for article (PubMed ID: 32269622)
1. miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma.
Wang X; Kan Y; Chen L; Ge P; Ding T; Zhai Q; Yu Y; Wang X; Zhao Z; Yang H; Liu X; Li L; Qiu L; Qian Z; Zhang H; Wang Y; Zhao H
Oncol Lett; 2020 May; 19(5):3487-3494. PubMed ID: 32269622
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphoma.
Chen L; Kan Y; Wang X; Ge P; Ding T; Zhai Q; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Liu X; Li L; Qiu L; Zhang H; Qian Z; Zhao H
Oncol Lett; 2020 Oct; 20(4):93. PubMed ID: 32831912
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
4. Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Qian Z; Chen L; Wang X; Kan Y; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Ge P; Ding T; Zhai Q; Zhao H
Clin Exp Med; 2022 May; 22(2):183-191. PubMed ID: 34427833
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Bcl-2 gene and its effect on prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma].
Zhang L; Zhao H; Li X; Xia B; Zheng H; Li H; Sun B; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2014 Oct; 36(10):755-60. PubMed ID: 25567306
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
7. Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma.
Chen F; Liu S; Zhou Y; Shen H; Zuo X
Hematology; 2016 Aug; 21(7):399-403. PubMed ID: 27077767
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].
Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY
Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-21 predicts the prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma.
Ji Q; Jiang T; Su J; Zhang S; Li C; Yang X; Wu X; Yao J; Yuan D; Wang J
Acta Biochim Pol; 2022 Jun; 69(2):379-385. PubMed ID: 35691029
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma.
Wang WL; Yang C; Han XL; Wang R; Huang Y; Zi YM; Li JD
Med Oncol; 2014 Apr; 31(4):919. PubMed ID: 24659264
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Lymphocyte/Monocyte Ratio on Clinical Features and Prognosis of Patients with Primary Gastrointestinal Diffuse Large B Cell Lymphoma].
Xu YX; Zhang YG; Xu CL; Liu NJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1404-1409. PubMed ID: 27784365
[TBL] [Abstract][Full Text] [Related]
13. High pretreatment plasma D-dimer levels predict poor survival in patients with diffuse large B-cell lymphoma in the real world.
Huang H; Fan L; Fu D; Lin Q; Shen J
Transl Cancer Res; 2021 Apr; 10(4):1723-1731. PubMed ID: 35116497
[TBL] [Abstract][Full Text] [Related]
14. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
[TBL] [Abstract][Full Text] [Related]
15. [Expression and Clinical Significance of MicroRNA-195 in Patients with Diffuse Large B Cell Lymphoma].
Liu RD; Zhuang W; Qi JD; Li CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):160-164. PubMed ID: 32027270
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
[TBL] [Abstract][Full Text] [Related]
17. [Significance of Peripheral Blood Lymphatic to Monocyte Ratio in the Progress of PGI-DLBCL].
Sun KM; Sang W; Xu LY; Yan DM; Song XG; Sun C; Sun XK; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1118-1122. PubMed ID: 31418366
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-383-5p predicts favorable prognosis and inhibits the progression of diffuse large B-cell lymphoma.
Chen LY; Han BQ; Zhang XM; Yu XB; Yao DD; Yu LQ
Oncol Lett; 2021 Jul; 22(1):515. PubMed ID: 33986875
[TBL] [Abstract][Full Text] [Related]
20. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
Yang Y; Wang L; Ma Y; Han T; Huang M
Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
